EPHA1-AS1, EPHA1 antisense RNA 1, 285965
N. diseases: 2; N. variants: 10
Source: ALL
Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
0.810 | GeneticVariation | GWASCAT | Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project. | 31473137 | 2019 | |||||||
|
|
|
A | 0.810 | GeneticVariation | GWASCAT | Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. | 30617256 | 2019 | ||||||
|
|
|
0.810 | GeneticVariation | BEFREE | These findings may further provide important supplementary information about the regulating mechanisms of rs11767557 variant in AD risk. | 29332039 | 2018 | |||||||
|
|
|
0.810 | GeneticVariation | GWASCAT | GWAS on family history of Alzheimer's disease. | 29777097 | 2018 | |||||||
|
|
|
0.810 | GeneticVariation | BEFREE | This study suggests EPHA1 (rs11771145) interferes with the pathological alteration of the hippocampus and the lateral occipitotemporal and inferior temporal gyri throughout the AD process, leading to a lower risk of AD. | 25182741 | 2015 | |||||||
|
|
|
G | 0.810 | GeneticVariation | GWASDB | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 24162737 | 2013 | ||||||
|
|
|
G | 0.810 | GeneticVariation | GWASCAT | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 24162737 | 2013 | ||||||
|
|
|
0.810 | GeneticVariation | GWASCAT | Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. | 21460841 | 2011 | |||||||
|
|
|
0.810 | GeneticVariation | GWASDB | Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. | 21460841 | 2011 | |||||||
|
|
|
0.810 | GeneticVariation | GWASDB | Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. | 21460841 | 2011 | |||||||
|
|
|
T | 0.700 | GeneticVariation | GWASCAT | Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. | 30617256 | 2019 | ||||||
|
|
|
T | 0.700 | GeneticVariation | GWASCAT | Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. | 30617256 | 2019 | ||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | GWAS on family history of Alzheimer's disease. | 29777097 | 2018 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | GWAS on family history of Alzheimer's disease. | 29777097 | 2018 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | GWAS on family history of Alzheimer's disease. | 29777097 | 2018 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | GWAS on family history of Alzheimer's disease. | 29777097 | 2018 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | GWAS on family history of Alzheimer's disease. | 29777097 | 2018 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | GWAS on family history of Alzheimer's disease. | 29777097 | 2018 |